ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Crohn’s Disease Diagnostic and Therapeutic Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-38A13859
Home | Market Reports | Health| Health Conditions
Global Crohn s Disease Diagnostic and Therapeutic Market Research Report 2023
BUY CHAPTERS

Global Crohn’s Disease Diagnostic and Therapeutic Market Insights, Forecast to 2030

Code: QYRE-Auto-38A13859
Report
December 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Genetech
Johnson & Johnson
Pfizer Inc
Prometheus Laboratories
Salix Pharmaceuticals
Celgene
Takeda Pharmaceutical

Crohn’s Disease Diagnostic and Therapeutic Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Crohn’s Disease Diagnostic and Therapeutic Market

Crohn’s Disease Diagnostic and Therapeutic Market

Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.
Market Analysis and Insights: Global Crohn’s Disease Diagnostic and Therapeutic Market
The global Crohn’s Disease Diagnostic and Therapeutic market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
This market is closely related to the pharmaceutical market. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Crohn’s Disease Diagnostic and Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Crohn’s Disease Diagnostic and Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Crohn’s Disease Diagnostic and Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Crohn’s Disease Diagnostic and Therapeutic revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Crohn’s Disease Diagnostic and Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Crohn’s Disease Diagnostic and Therapeutic revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Crohn’s Disease Diagnostic and Therapeutic Market Report

Report Metric Details
Report Name Crohn’s Disease Diagnostic and Therapeutic Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Medical Research Institute
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbvie, Celgene, Genetech, Johnson & Johnson, Pfizer, Prometheus Laboratories, Salix Pharmaceuticals, Takeda Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Crohn’s Disease Diagnostic and Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Crohn’s Disease Diagnostic and Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Crohn’s Disease Diagnostic and Therapeutic revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Crohn’s Disease Diagnostic and Therapeutic Market report?

Ans: The main players in the Crohn’s Disease Diagnostic and Therapeutic Market are Abbvie, Celgene, Genetech, Johnson & Johnson, Pfizer, Prometheus Laboratories, Salix Pharmaceuticals, Takeda Pharmaceutical

What are the Application segmentation covered in the Crohn’s Disease Diagnostic and Therapeutic Market report?

Ans: The Applications covered in the Crohn’s Disease Diagnostic and Therapeutic Market report are Hospital, Medical Research Institute, Other

What are the Type segmentation covered in the Crohn’s Disease Diagnostic and Therapeutic Market report?

Ans: The Types covered in the Crohn’s Disease Diagnostic and Therapeutic Market report are Diagnostics, Treatment

Recommended Reports

Disease Diagnostics

Diagnostic Devices

Therapeutics Market

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Diagnostics
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Research Institute
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Perspective (2019-2030)
2.2 Global Crohn’s Disease Diagnostic and Therapeutic Growth Trends by Region
2.2.1 Crohn’s Disease Diagnostic and Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Crohn’s Disease Diagnostic and Therapeutic Market Dynamics
2.3.1 Crohn’s Disease Diagnostic and Therapeutic Industry Trends
2.3.2 Crohn’s Disease Diagnostic and Therapeutic Market Drivers
2.3.3 Crohn’s Disease Diagnostic and Therapeutic Market Challenges
2.3.4 Crohn’s Disease Diagnostic and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Crohn’s Disease Diagnostic and Therapeutic by Players
3.1.1 Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio
3.4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2023
3.5 Global Key Players of Crohn’s Disease Diagnostic and Therapeutic Head office and Area Served
3.6 Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Product and Application
3.7 Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Type
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2025-2030)
5 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Application
5.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size (2019-2030)
6.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
6.2.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024)
6.2.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2025-2030)
6.2.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2019-2030)
6.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
6.3.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024)
6.3.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2025-2030)
6.3.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2019-2030)
6.4 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
6.4.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
6.4.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size (2019-2030)
7.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
7.2.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024)
7.2.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2025-2030)
7.2.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2019-2030)
7.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
7.3.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024)
7.3.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2025-2030)
7.3.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2019-2030)
7.4 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
7.4.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
7.4.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Crohn’s Disease Diagnostic and Therapeutic Market Size (2019-2030)
8.2 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
8.2.1 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024)
8.2.2 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2025-2030)
8.2.3 China Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2019-2030)
8.3 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
8.3.1 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024)
8.3.2 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2025-2030)
8.3.3 China Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size (2019-2030)
9.2 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
9.2.1 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024)
9.2.2 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2025-2030)
9.2.3 Asia Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2019-2030)
9.3 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
9.3.1 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024)
9.3.2 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2025-2030)
9.3.3 Asia Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2019-2030)
9.4 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Region
9.4.1 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2019-2024)
9.4.3 Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Introduction
11.1.4 Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.1.5 Abbvie Recent Developments
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Introduction
11.2.4 Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.2.5 Celgene Recent Developments
11.3 Genetech
11.3.1 Genetech Company Details
11.3.2 Genetech Business Overview
11.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Introduction
11.3.4 Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.3.5 Genetech Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Introduction
11.4.4 Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Introduction
11.5.4 Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.5.5 Pfizer Recent Developments
11.6 Prometheus Laboratories
11.6.1 Prometheus Laboratories Company Details
11.6.2 Prometheus Laboratories Business Overview
11.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Introduction
11.6.4 Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.6.5 Prometheus Laboratories Recent Developments
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Details
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Introduction
11.7.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.7.5 Salix Pharmaceuticals Recent Developments
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Introduction
11.8.4 Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
11.8.5 Takeda Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
AbbVie
Genetech
Johnson & Johnson
Pfizer Inc
Prometheus Laboratories
Salix Pharmaceuticals
Celgene
Takeda Pharmaceutical
List of Tables
    Table 1. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Diagnostics
    Table 3. Key Players of Treatment
    Table 4. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2019-2024)
    Table 8. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2025-2030)
    Table 10. Crohn’s Disease Diagnostic and Therapeutic Market Trends
    Table 11. Crohn’s Disease Diagnostic and Therapeutic Market Drivers
    Table 12. Crohn’s Disease Diagnostic and Therapeutic Market Challenges
    Table 13. Crohn’s Disease Diagnostic and Therapeutic Market Restraints
    Table 14. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Share by Players (2019-2024)
    Table 16. Global Top Crohn’s Disease Diagnostic and Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2023)
    Table 17. Global Crohn’s Disease Diagnostic and Therapeutic Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Headquarters and Area Served
    Table 20. Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Product and Application
    Table 21. Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2019-2024)
    Table 25. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2025-2030)
    Table 27. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Share by Application (2019-2024)
    Table 29. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Share by Application (2025-2030)
    Table 31. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Crohn’s Disease Diagnostic and Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Crohn’s Disease Diagnostic and Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Crohn’s Disease Diagnostic and Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Abbvie Company Details
    Table 64. Abbvie Business Overview
    Table 65. Abbvie Crohn’s Disease Diagnostic and Therapeutic Product
    Table 66. Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 67. Abbvie Recent Developments
    Table 68. Celgene Company Details
    Table 69. Celgene Business Overview
    Table 70. Celgene Crohn’s Disease Diagnostic and Therapeutic Product
    Table 71. Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 72. Celgene Recent Developments
    Table 73. Genetech Company Details
    Table 74. Genetech Business Overview
    Table 75. Genetech Crohn’s Disease Diagnostic and Therapeutic Product
    Table 76. Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 77. Genetech Recent Developments
    Table 78. Johnson & Johnson Company Details
    Table 79. Johnson & Johnson Business Overview
    Table 80. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Product
    Table 81. Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 82. Johnson & Johnson Recent Developments
    Table 83. Pfizer Company Details
    Table 84. Pfizer Business Overview
    Table 85. Pfizer Crohn’s Disease Diagnostic and Therapeutic Product
    Table 86. Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 87. Pfizer Recent Developments
    Table 88. Prometheus Laboratories Company Details
    Table 89. Prometheus Laboratories Business Overview
    Table 90. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Product
    Table 91. Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 92. Prometheus Laboratories Recent Developments
    Table 93. Salix Pharmaceuticals Company Details
    Table 94. Salix Pharmaceuticals Business Overview
    Table 95. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Product
    Table 96. Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 97. Salix Pharmaceuticals Recent Developments
    Table 98. Takeda Pharmaceutical Company Details
    Table 99. Takeda Pharmaceutical Business Overview
    Table 100. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Product
    Table 101. Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 102. Takeda Pharmaceutical Recent Developments
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Type: 2023 VS 2030
    Figure 3. Diagnostics Features
    Figure 4. Treatment Features
    Figure 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Case Studies
    Figure 8. Medical Research Institute Case Studies
    Figure 9. Other Case Studies
    Figure 10. Crohn’s Disease Diagnostic and Therapeutic Report Years Considered
    Figure 11. Global Crohn’s Disease Diagnostic and Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Crohn’s Disease Diagnostic and Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region: 2023 VS 2030
    Figure 14. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players in 2023
    Figure 15. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2023
    Figure 17. North America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2019-2030)
    Figure 19. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2019-2030)
    Figure 20. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2019-2030)
    Figure 21. United States Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2019-2030)
    Figure 25. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2019-2030)
    Figure 26. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2019-2030)
    Figure 27. Germany Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Crohn’s Disease Diagnostic and Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2019-2030)
    Figure 35. China Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2019-2030)
    Figure 36. Asia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2019-2030)
    Figure 38. Asia Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2019-2030)
    Figure 39. Asia Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2019-2030)
    Figure 40. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2019-2030)
    Figure 50. Brazil Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Abbvie Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
    Figure 57. Celgene Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
    Figure 58. Genetech Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
    Figure 60. Pfizer Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
    Figure 61. Prometheus Laboratories Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
    Figure 62. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
    Figure 63. Takeda Pharmaceutical Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Inflammatory Bowel Disease Relief Market Insights Forecast to 2030
Global Inflammatory Bowel Disease Therapy Market Insights Forecast to 2030
Crohn s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In vitro Inflammatory Bowel Disease Diagnostic Market Research Report 2024
Global Crohn s Disease Market Research Report 2024
Inflammatory Bowel Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Crohn s Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Crohn s Disease Drug Market Research Report 2024
Global Crohn s Disease Treatment Drug Market Research Report 2025
Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global IBD Ulcerative Colitis and Crohn s Disease Treatment Market Insights Forecast to 2030
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gaucher Disease GD Drugs Market Insights Forecast to 2030
Inflammatory Bowel Disease IBD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Necrotic Enteritis Drug Market Insights Forecast to 2030
Inflammatory Bowel Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Prescription Gastrointestinal Drugs Market Research Report 2024
Inflammatory Bowel Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pouchitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions